FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Frederic Quitkin

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Devices

Placebos

Procedures

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Jonathan W Stewart; Patrick J McGrath; Frederic M Quitkin; Donald F Klein
DSM-IV depression with atypical features: is it valid?
Jonathan W Stewart; Patrick J McGrath; Rodeborah A Deliyannides; Frederic M Quitkin
Does dual antidepressant therapy as initial treatment hasten and increase remission from depression?
Gerard E Bruder; James P Sedoruk; Jonathan W Stewart; Patrick J McGrath; Frederic M Quitkin; Craig E Tenke
Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Frederic Quitkin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Jonathan W Stewart; Patrick J McGrath; Frederic M Quitkin; Donald F Klein
DSM-IV depression with atypical features: is it valid?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(13):2625-32.
2009: Jonathan W Stewart; Patrick J McGrath; Rodeborah A Deliyannides; Frederic M Quitkin
Does dual antidepressant therapy as initial treatment hasten and increase remission from depression?
Journal of psychiatric practice 2009;15(5):337-45.
2008: Gerard E Bruder; James P Sedoruk; Jonathan W Stewart; Patrick J McGrath; Frederic M Quitkin; Craig E Tenke
Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings.
Biological psychiatry 2008;63(12):1171-7.
2007: Cristina Cusin; Maurizio Fava; Jay D Amsterdam; Frederic M Quitkin; Frederick W Reimherr; Charles Beasley; Jerrold F Rosenbaum; Roy H Perlis
Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications.
The Journal of clinical psychiatry 2007;68(1):52-7.
2007: Roy H Perlis; Charles Beasley; James D Wines; Roy N Tamura; Cristina Cusin; Deborah Shear; Jay D Amsterdam; Frederic M Quitkin; Robert E Strong; Jerrold F Rosenbaum; Maurizio Fava
Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes.
Psychotherapy and psychosomatics 2007;76(1):40-6.
2006: Patrick J McGrath; Jonathan W Stewart; Frederic M Quitkin; Ying Chen; Jonathan E Alpert; Andrew A Nierenberg; Maurizio Fava; Jianfeng Cheng; Eva Petkova
Predictors of relapse in a prospective study of fluoxetine treatment of major depression.
The American journal of psychiatry 2006;163(9):1542-8.
2006: Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski; Michael E Thase; Frederic M Quitkin; Diane Warden; Louise Ritz; Andrew A Nierenberg; Barry D Lebowitz; Melanie Biggs; James F Luther; Kathy Shores-Wilson; A John Rush
Medication augmentation after the failure of SSRIs for depression.
The New England journal of medicine 2006;354(12):1243-52.
2006: Bonnie P Taylor; Gerard E Bruder; Jonathan W Stewart; Patrick J McGrath; Jeffrey Halperin; Howard Ehrlichman; Frederic M Quitkin
Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients.
The American journal of psychiatry 2006;163(1):73-8.
2005: Frederic M Quitkin; Patrick J McGrath; Jonathan W Stewart; donald klein; Donald C Ross
Accurate meta-analytical assessment of "true antidepressant effects" needed.
The Journal of clinical psychiatry 2005;66(9):1192; author reply 1192-3.
2005: Frederic M Quitkin; Patrick J McGrath; Jonathan W Stewart; Deborah Deliyannides; Bonnie P Taylor; Carrie A Davies; donald klein
Remission rates with 3 consecutive antidepressant trials: effectiveness for depressed outpatients.
The Journal of clinical psychiatry 2005;66(6):670-6.
2005: Jonathan W Stewart; Frederic M Quitkin; Patrick J McGrath; donald klein
Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
Journal of affective disorders 2005;86(2-3):161-7.
2005: Bonnie P Taylor; Frederic M Quitkin; Patrick J McGrath; Jonathan W Stewart
Do antihypertensives make tranylcypromine safer? Three case reports.
The Journal of clinical psychiatry 2005;66(5):657-8.
2005: Lori Davis; John A Rush; Stephen R Wisniewski; Kayla Rice; Paolo Cassano; Michele E Jewell; Melanie Biggs; Kathy Shores-Wilson; Balasubramani G.K.; Mustafa M Husain; Frederic M Quitkin; Patrick J McGrath
Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.
Comprehensive psychiatry 2005;46(2):81-9.
2004: Gerard E Bruder; Jonathan W Stewart; Patrick J McGrath; Deborah Deliyannides; Frederic M Quitkin
Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(9):1752-61.
2004: Stephen R Wisniewski; Diane Stegman; Madhukar Trivedi; Mustafa M Husain; Heather Eng; Kathy Shores-Wilson; James F Luther; Melanie Biggs; Diane Burroughs; A Louise Ritz; Maurizio Fava; Frederic M Quitkin; A John Rush
Methods of testing feasibility for sequenced treatment alternatives to relieve depression (STAR*D).
Journal of psychiatric research 2004;38(3):241-8.
2004: Andrew A Nierenberg; Frederic M Quitkin; Charlotte Kremer; Martin B Keller; Michael E Thase
Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(5):1012-8.
2004: A John Rush; Maurizio Fava; Stephen R Wisniewski; Philip W Lavori; Madhukar H Trivedi; Harold A Sackeim; Michael E Thase; Andrew A Nierenberg; Frederic M Quitkin; T Michael Kashner; David J Kupfer; Jerrold F Rosenbaum; Jonathan Alpert; Jonathan W Stewart; Patrick J McGrath; Melanie Biggs; Kathy Shores-Wilson; Barry D Lebowitz; Louise Ritz; George Niederehe
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
Controlled clinical trials 2004;25(1):119-42.
2004: Gerard E Bruder; Franklin R Schneier; Jonathan W Stewart; Patrick J McGrath; Frederic M Quitkin
Left hemisphere dysfunction during verbal dichotic listening tests in patients who have social phobia with or without comorbid depressive disorder.
The American journal of psychiatry 2004;161(1):72-8.
2003: Stephen J Donovan; Edward V Nunes; Jonathan W Stewart; Don Ross; Frederic M Quitkin; Peter S Jensen; donald klein
"Outer-directed irritability": a distinct mood syndrome in explosive youth with a disruptive behavior disorder?
The Journal of clinical psychiatry 2003;64(6):698-701.
2003: Maurizio Fava; A John Rush; Madhukar H Trivedi; Andrew A Nierenberg; Michael E Thase; Harold A Sackeim; Frederic M Quitkin; Steven Wisniewski; Philip W Lavori; Jerrold F Rosenbaum; David J Kupfer
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.
The Psychiatric clinics of North America 2003;26(2):457-94, x.
2003: Jonathan W Stewart; Gerard E Bruder; Patrick J McGrath; Frederic M Quitkin
Do age of onset and course of illness define biologically distinct groups within atypical depression?
Journal of abnormal psychology 2003;112(2):253-62.
2003: Frederic M Quitkin; Patrick J McGrath; Jonathan W Stewart; donald klein
A reappraisal of atypical depression.
The American journal of psychiatry 2003;160(4):798-800; author reply 800-1.
2003: Frederic M Quitkin; Eva Petkova; Patrick J McGrath; Bonnie Taylor; Charles Beasley; Jonathan Stewart; Jay D Amsterdam; Maurizio Fava; Jerrold Rosenbaum; Frederick W Reimherr; Jan Fawcett; Ying Chen; Donald Klein
When should a trial of fluoxetine for major depression be declared failed?
The American journal of psychiatry 2003;160(4):734-40.
2003: Maurizio Fava; George I Papakostas; Timothy Petersen; Yasmin Mahal; Frederic M Quitkin; Jonathan Stewart; Patrick McGrath
Switching to bupropion in fluoxetine-resistant major depressive disorder.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2003;15(1):17-22.
2003: Frederic M Quitkin; Amir Garakani; Katie E Kelly
Electrolyte-balanced sports drink for polydipsia-hyponatremia in schizophrenia.
The American journal of psychiatry 2003;160(2):385-6.
2002: Frederic M Quitkin; Jonathan W Stewart; Patrick J McGrath; Bonnie P Taylor; Mayra S Tisminetzky; Eva Petkova; Ying Chen; Guoguang Ma; donald klein
Are there differences between women's and men's antidepressant responses?
The American journal of psychiatry 2002;159(11):1848-54.
2002: Vito Agosti; Frederic M Quitkin; Jonathan W Stewart; Patrick J McGrath
Somatization as a predictor of medication discontinuation due to adverse events.
International clinical psychopharmacology 2002;17(6):311-4.
2002: Stuart A Montgomery; Per Bech; Pierre Blier; Hans-Jürgen Möller; Andrew A Nierenberg; Roger M Pinder; Frederic M Quitkin; Paul-Egbert Reimitz; Jerrold F Rosenbaum; john rush; H H Stassen; Michael E Thase
Selecting methodologies for the evaluation of differences in time to response between antidepressants.
The Journal of clinical psychiatry 2002;63(8):694-9.
2002: Donald C Ross; Frederic M Quitkin; donald klein
A typological model for estimation of drug and placebo effects in depression.
Journal of clinical psychopharmacology 2002;22(4):414-8.
2002: Gerard E Bruder; Jonathan W Stewart; Patrick J McGrath; Guoguang Julie Ma; Bruce E Wexler; Frederic M Quitkin
Atypical depression: enhanced right hemispheric dominance for perceiving emotional chimeric faces.
Journal of abnormal psychology 2002;111(3):446-54.
2002: Gerard E Bruder; Jürgen Kayser; Craig E Tenke; Paul Leite; Franklin R Schneier; Jonathan W Stewart; Frederic M Quitkin
Cognitive ERPs in depressive and anxiety disorders during tonal and phonetic oddball tasks.
Clinical EEG (electroencephalography) 2002;33(3):119-24.
2002: David J Brunswick; Jay D Amsterdam; Jan Fawcett; Frederic M Quitkin; Frederick W Reimherr; Jerrold F Rosenbaum; Charles Beasley
Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment.
Journal of affective disorders 2002;68(2-3):243-9.
2002: Jonathan W Stewart; Patrick J McGrath; Frederic M Quitkin
Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(2):237-45.
2001: David J Brunswick; Jay D Amsterdam; Jan Fawcett; Frederic M Quitkin; Frederick W Reimherr; Jerrold F Rosenbaum; Charles Beasley
Fluoxetine and norfluoxetine plasma levels after discontinuing fluoxetine therapy.
Journal of clinical psychopharmacology 2001;21(6):616-8.
2001: Philip W Lavori; john rush; Stephen R Wisniewski; Jonathan Alpert; M Fava; D J Kupfer; Andrew A Nierenberg; Frederic M Quitkin; Harold A Sackeim; Michael E Thase; Madhukar Trivedi
Strengthening clinical effectiveness trials: equipoise-stratified randomization.
Biological psychiatry 2001;50(10):792-801.
2001: Frederic M Quitkin; Bonnie P Taylor; C Kremer
Does mirtazapine have a more rapid onset than SSRIs?
The Journal of clinical psychiatry 2001;62(5):358-61.
2001: Gerard E Bruder; Jonathan W Stewart; Craig E Tenke; Patrick J McGrath; Paul Leite; N Bhattacharya; Frederic M Quitkin
Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant.
Biological psychiatry 2001;49(5):416-25.
2000: Patrick J McGrath; Edward V Nunes; Frederic M Quitkin
Current concepts in the treatment of depression in alcohol-dependent patients.
The Psychiatric clinics of North America 2000;23(4):695-711, V.
2000: Patrick J McGrath; Jonathan W Stewart; Eva Petkova; Frederic M Quitkin; Jay D Amsterdam; Jan Fawcett; Frederick W Reimherr; J F Rosenbaum; Charles Beasley
Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression.
The Journal of clinical psychiatry 2000;61(7):518-24.
2000: Eva Petkova; Frederic M Quitkin; Patrick J McGrath; Jonathan W Stewart; donald klein
A method to quantify rater bias in antidepressant trials.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(6):559-65.
2000: Jürgen Kayser; Gerard E Bruder; Craig E Tenke; JE Stewart; Frederic M Quitkin
Event-related potentials (ERPs) to hemifield presentations of emotional stimuli: differences between depressed patients and healthy adults in P3 amplitude and asymmetry.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 2000;36(3):211-36.
2000: S J Donovan; Jonathan W Stewart; Edward V Nunes; Frederic M Quitkin; M Parides; W Daniel; E Susser; D F Klein
Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.
The American journal of psychiatry 2000;157(5):818-20.
2000: Frederic M Quitkin; donald klein
What conditions are necessary to assess antidepressant efficacy?
Archives of general psychiatry 2000;57(4):323-4.
2000: Patrick J McGrath; Jonathan W Stewart; MN Janal; Eva Petkova; Frederic M Quitkin; donald klein
A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression.
The American journal of psychiatry 2000;157(3):344-50.
2000: Frederic M Quitkin; Judith G Rabkin; J Gerald; John M Davis; donald klein
Validity of clinical trials of antidepressants.
The American journal of psychiatry 2000;157(3):327-37.
1999: Jonathan W Stewart; Frederic M Quitkin; Patrick J McGrath; Gerard E Bruder
Do tricyclic responders have different brain laterality?
Journal of abnormal psychology 1999;108(4):707-10.
1999: Jay D Amsterdam; Felipe Garcia-España; Jan Fawcett; Frederic M Quitkin; Frederick W Reimherr; J Rosenbaum; Charles Beasley
Fluoxetine efficacy in menopausal women with and without estrogen replacement.
Journal of affective disorders 1999;55(1):11-7.
1999: David Michelson; Jay D Amsterdam; Frederic M Quitkin; Frederick W Reimherr; J F Rosenbaum; John M Zajecka; Karen Sundell; Y Kim; Charles Beasley
Changes in weight during a 1-year trial of fluoxetine.
The American journal of psychiatry 1999;156(8):1170-6.
1999: John M Zajecka; Jay D Amsterdam; Frederic M Quitkin; Frederick W Reimherr; J F Rosenbaum; R N Tamura; Karen Sundell; David Michelson; Charles Beasley
Changes in adverse events reported by patients during 6 months of fluoxetine therapy.
The Journal of clinical psychiatry 1999;60(6):389-94.
1999: Frederic M Quitkin
Placebos, drug effects, and study design: a clinician's guide.
The American journal of psychiatry 1999;156(6):829-36.
1999: Gerard E Bruder; Bruce E Wexler; Jonathan W Stewart; L H Price; Frederic M Quitkin
Perceptual asymmetry differences between major depression with or without a comorbid anxiety disorder: a dichotic listening study.
Journal of abnormal psychology 1999;108(2):233-9.
1999: Jay D Amsterdam; F Garcia-Espana; Jan Fawcett; Frederic M Quitkin; Frederick W Reimherr; Jerrold F Rosenbaum; Charles Beasley
Blood pressure changes during short-term fluoxetine treatment.
Journal of clinical psychopharmacology 1999;19(1):9-14.
1999: Gerard E Bruder; Craig E Tenke; Jonathan W Stewart; P J McGrath; Frederic M Quitkin
Predictors of therapeutic response to treatments for depression: a review of electrophysiologic and dichotic listening studies.
CNS spectrums 1999;4(8):30-6.
1998: Jay D Amsterdam; Felipe Garcia-España; Jan Fawcett; Frederic M Quitkin; Frederick W Reimherr; Jerrold F Rosenbaum; Edward Schweizer; Charles Beasley
Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.
Journal of clinical psychopharmacology 1998;18(6):435-40.
1998: Frederic M Quitkin; Patrick J McGrath; Jonathan W Stewart; Katja Ocepek-Welikson; Bonnie P Taylor; Edward Nunes; D Delivannides; Vito Agosti; Stephen Donovan; D Ross; Eva Petkova; donald klein
Placebo run-in period in studies of depressive disorders. Clinical, heuristic and research implications.
The British journal of psychiatry : the journal of mental science 1998;173():242-8.
1998: Frederick W Reimherr; Jay D Amsterdam; Frederic M Quitkin; J F Rosenbaum; M Fava; John M Zajecka; Charles Beasley; David Michelson; P Roback; Karen Sundell
Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment.
The American journal of psychiatry 1998;155(9):1247-53.
1998: John M Zajecka; Jan Fawcett; Jay D Amsterdam; Frederic M Quitkin; Frederick W Reimherr; J Rosenbaum; David Michelson; Charles Beasley
Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study.
Journal of clinical psychopharmacology 1998;18(3):193-7.
1998: J W Stewart; Frederic M Quitkin; Patrick J McGrath; Jay D Amsterdam; M Fava; Jan Fawcett; Frederick W Reimherr; J Rosenbaum; Charles Beasley; P Roback
Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo.
Archives of general psychiatry 1998;55(4):334-43.
1998: Edward V Nunes; Frederic M Quitkin; Stephen Donovan; Deborah Deliyannides; Katja Ocepek-Welikson; T Koenig; R Brady; Patrick J McGrath; G Woody
Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial.
Archives of general psychiatry 1998;55(2):153-60.
1998: Gerard E Bruder; Craig E Tenke; JP Towey; Paul Leite; Regan Fong; JE Stewart; Patrick J McGrath; Frederic M Quitkin
Brain ERPs of depressed patients to complex tones in an oddball task: relation of reduced P3 asymmetry to physical anhedonia.
Psychophysiology 1998;35(1):54-63.
1997: Jay D Amsterdam; Jan Fawcett; Frederic M Quitkin; Frederick W Reimherr; Jerrold F Rosenbaum; David Michelson; Mady Hornig; Charles Beasley
Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.
The American journal of psychiatry 1997;154(7):963-9.
1997: Gerard E Bruder; Regan Fong; Craig E Tenke; Paul Leite; JP Towey; JE Stewart; Patrick J McGrath; Frederic M Quitkin
Regional brain asymmetries in major depression with or without an anxiety disorder: a quantitative electroencephalographic study.
Biological psychiatry 1997;41(9):939-48.
1997: Gerard E Bruder; Jonathan W Stewart; M A Mercier; Vito Agosti; Paul Leite; Stephen Donovan; Frederic M Quitkin
Outcome of cognitive-behavioral therapy for depression: relation to hemispheric dominance for verbal processing.
Journal of abnormal psychology 1997;106(1):138-44.
1997: S J Donovan; E S Susser; Edward V Nunes; Jonathan W Stewart; Frederic M Quitkin; donald klein
Divalproex treatment of disruptive adolescents: a report of 10 cases.
The Journal of clinical psychiatry 1997;58(1):12-5.
1996: Frederic M Quitkin; Patrick J McGrath; Jonathan W Stewart; B P Taylor; donald klein
Can the effects of antidepressants be observed in the first two weeks of treatment?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(4):390-4.
1996: Frederic M Quitkin; Patrick J McGrath; Jonathan W Stewart; Katja Ocepek-Welikson; B P Taylor; E Nunes; D Deliyannides; Vito Agosti; Stephen Donovan; Eva Petkova; donald klein
Chronological milestones to guide drug change. When should clinicians switch antidepressants?
Archives of general psychiatry 1996;53(9):785-92.
1996: Gerard E Bruder; M W Otto; Patrick J McGrath; Jonathan W Stewart; M Fava; J F Rosenbaum; Frederic M Quitkin
Dichotic listening before and after fluoxetine treatment for major depression: relations of laterality to therapeutic response.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(2):171-9.
1996: Patrick J McGrath; Edward V Nunes; Jonathan W Stewart; D Goldman; Vito Agosti; Katja Ocepek-Welikson; Frederic M Quitkin
Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial.
Archives of general psychiatry 1996;53(3):232-40.
1995: Edward V Nunes; Patrick J McGrath; Frederic M Quitkin; Katja Ocepek-Welikson; Jonathan W Stewart; T Koenig; S Wager; D F Klein
Imipramine treatment of cocaine abuse: possible boundaries of efficacy.
Drug and alcohol dependence 1995;39(3):185-95.
1995: Gerard E Bruder; Craig E Tenke; Jonathan W Stewart; J P Towey; Paul Leite; M Voglmaier; Frederic M Quitkin
Brain event-related potentials to complex tones in depressed patients: relations to perceptual asymmetry and clinical features.
Psychophysiology 1995;32(4):373-81.
1995: Edward V Nunes; Patrick J McGrath; Frederic M Quitkin
Treating anxiety in patients with alcoholism.
The Journal of clinical psychiatry 1995;56 Suppl 2():3-9.
1994: Patrick J McGrath; Jonathan W Stewart; Frederic M Quitkin; S Wager; S W Jenkins; D G Archibald; J C Stringfellow; D S Robinson
Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement.
Journal of clinical psychopharmacology 1994;14(5):347-52.
1994: Patrick J McGrath; Jonathan W Stewart; E N Nunes; Frederic M Quitkin
Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
The Journal of clinical psychiatry 1994;55(8):336-9.
1994: Edward V Nunes; Stephen Donovan; R Brady; Frederic M Quitkin
Evaluation and treatment of mood and anxiety disorders in opioid-dependent patients.
Journal of psychoactive drugs 1994;26(2):147-53.
1994: Stephen Donovan; Frederic M Quitkin; Jonathan W Stewart; Katja Ocepek-Welikson; W Harrison; Patrick J McGrath; Edward V Nunes; S Wager; E Tricamo
Duration of antidepressant trials: clinical and research implications.
Journal of clinical psychopharmacology 1994;14(1):64-6.
1994: R Rothschild; H M Quitkin; Frederic M Quitkin; Jonathan W Stewart; Katja Ocepek-Welikson; Patrick J McGrath; E Tricamo
A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives.
The International journal of eating disorders 1994;15(1):1-9.
1994: E Nunes; Frederic M Quitkin; R Brady; T Post-Koenig
Antidepressant treatment in methadone maintenance patients.
Journal of addictive diseases 1994;13(3):13-24.
1993: Jonathan W Stewart; Patrick J McGrath; Frederic M Quitkin; Judith G Rabkin; W Harrison; S Wager; E Nunes; Katja Ocepek-Welikson; E Tricamo
Chronic depression: response to placebo, imipramine, and phenelzine.
Journal of clinical psychopharmacology 1993;13(6):391-6.
1993: Jonathan W Stewart; Patrick J McGrath; Judith G Rabkin; Frederic M Quitkin
Atypical depression. A valid clinical entity?
The Psychiatric clinics of North America 1993;16(3):479-95.
1993: Frederic M Quitkin; Jonathan W Stewart; Patrick J McGrath; E Tricamo; Judith G Rabkin; Katja Ocepek-Welikson; E Nunes; W Harrison; D F Klein
Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
The British journal of psychiatry. Supplement 1993;(21):30-4.
1993: Frederic M Quitkin
[Impact of personality factors in depression].
L'Encéphale 1993;19 Spec No 3():491-2.
1993: Edward V Nunes; Patrick J McGrath; Frederic M Quitkin; J P Stewart; W Harrison; E Tricamo; Katja Ocepek-Welikson
Imipramine treatment of alcoholism with comorbid depression.
The American journal of psychiatry 1993;150(6):963-5.
1993: Patrick J McGrath; Jonathan W Stewart; E Tricamo; E N Nunes; Frederic M Quitkin
Paradoxical mood shifts to euthymia or hypomania upon withdrawal of antidepressant agents.
Journal of clinical psychopharmacology 1993;13(3):224-5.
1993: Vito Agosti; Jonathan W Stewart; Frederic M Quitkin; Katja Ocepek-Welikson
How symptomatic do depressed patients remain after benefiting from medication treatment?
Comprehensive psychiatry 1993;34(3):182-6.
1993: Frederic M Quitkin; Jonathan W Stewart; Patrick J McGrath; E Nunes; Katja Ocepek-Welikson; E Tricamo; Judith G Rabkin; donald klein
Further evidence that a placebo response to antidepressants can be identified.
The American journal of psychiatry 1993;150(4):566-70.
1993: Frederic M Quitkin; Jonathan W Stewart; Patrick J McGrath; E Nunes; Katja Ocepek-Welikson; E Tricamo; Judith G Rabkin; D Ross; donald klein
Loss of drug effects during continuation therapy.
The American journal of psychiatry 1993;150(4):562-5.
1993: Jonathan W Stewart; M A Mercier; Vito Agosti; M Guardino; Frederic M Quitkin
Imipramine is effective after unsuccessful cognitive therapy: sequential use of cognitive therapy and imipramine in depressed outpatients.
Journal of clinical psychopharmacology 1993;13(2):114-9.
1993: Patrick J McGrath; Jonathan W Stewart; Edward V Nunes; Katja Ocepek-Welikson; Judith G Rabkin; Frederic M Quitkin; donald klein
A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression.
The American journal of psychiatry 1993;150(1):118-23.
1993: L Goehl; E Nunes; Frederic M Quitkin; I Hilton
Social networks and methadone treatment outcome: the costs and benefits of social ties.
The American journal of drug and alcohol abuse 1993;19(3):251-62.
1992: Gerard E Bruder; Jonathan W Stewart; J P Towey; D Friedman; Craig E Tenke; M M Voglmaier; Paul Leite; P Cohen; Frederic M Quitkin
Abnormal cerebral laterality in bipolar depression: convergence of behavioral and brain event-related potential findings.
Biological psychiatry 1992;32(1):33-47.
1992: Patrick J McGrath; Jonathan W Stewart; W M Harrison; Katja Ocepek-Welikson; Judith G Rabkin; E N Nunes; S G Wager; E Tricamo; Frederic M Quitkin; donald klein
Predictive value of symptoms of atypical depression for differential drug treatment outcome.
Journal of clinical psychopharmacology 1992;12(3):197-202.
1992: M A Mercier; Jonathan W Stewart; Frederic M Quitkin
A pilot sequential study of cognitive therapy and pharmacotherapy of atypical depression.
The Journal of clinical psychiatry 1992;53(5):166-70.
1992: Jonathan W Stewart; Patrick J McGrath; Frederic M Quitkin
Can mildly depressed outpatients with atypical depression benefit from antidepressants?
The American journal of psychiatry 1992;149(5):615-9.
1992: Jonathan W Stewart; Frederic M Quitkin; D F Klein
The pharmacotherapy of minor depression.
American journal of psychotherapy 1992;46(1):23-36.
1992: R Rothschild; Frederic M Quitkin
Review of the use of pattern analysis to differentiate true drug and placebo responses.
Psychotherapy and psychosomatics 1992;58(3-4):170-7.
1991: V Agosti; Jonathan W Stewart; Frederic M Quitkin
Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants.
Journal of affective disorders 1991;23(1):35-41.
1991: Gerard E Bruder; J P Towey; Jonathan W Stewart; D Friedman; Craig E Tenke; Frederic M Quitkin
Event-related potentials in depression: influence of task, stimulus hemifield and clinical features on P3 latency.
Biological psychiatry 1991;30(3):233-46.
1991: Edward V Nunes; Frederic M Quitkin; R Brady; Jonathan W Stewart
Imipramine treatment of methadone maintenance patients with affective disorder and illicit drug use.
The American journal of psychiatry 1991;148(5):667-9.
1991: Frederic M Quitkin; W Harrison; Jonathan W Stewart; Patrick J McGrath; E Tricamo; Katja Ocepek-Welikson; Judith G Rabkin; S G Wager; E Nunes; donald klein
Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design.
Archives of general psychiatry 1991;48(4):319-23.
1991: Vito Agosti; E Nunes; Jonathan W Stewart; Frederic M Quitkin
Patient factors related to early attrition from an outpatient cocaine research clinic: a preliminary report.
The International journal of the addictions 1991;26(3):327-34.
1991: Frederic M Quitkin; Patrick J McGrath; Judith G Rabkin; Jonathan W Stewart; W Harrison; Donald C Ross; E Tricamo; J Fleiss; J Markowitz; donald klein
Different types of placebo response in patients receiving antidepressants.
The American journal of psychiatry 1991;148(2):197-203.
1991: Frederic M Quitkin; Judith G Rabkin; Jonathan W Stewart; Patrick J McGrath; W Harrison; Donald C Ross; E Tricamo; J Fleiss; J Markowitz; donald klein
Heterogeneity of clinical response during placebo treatment.
The American journal of psychiatry 1991;148(2):193-6.
1990: Judith G Rabkin; Patrick J McGrath; Frederic M Quitkin; E Tricamo; Jonathan W Stewart; donald klein
Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression.
The American journal of psychiatry 1990;147(12):1622-6.
1990: Frederic M Quitkin; Patrick J McGrath; Jonathan W Stewart; W Harrison; E Tricamo; S G Wager; Katja Ocepek-Welikson; E Nunes; Judith G Rabkin; donald klein
Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
Archives of general psychiatry 1990;47(10):935-41.
1990: Eric Hollander; Edward V Nunes; C M DeCaria; Frederic M Quitkin; T Cooper; S Wager; D F Klein
Dopaminergic sensitivity and cocaine abuse: response to apomorphine.
Psychiatry research 1990;33(2):161-9.
1990: Jonathan W Stewart; Frederic M Quitkin; Michael Terman; Jiuan Su Terman
Is seasonal affective disorder a variant of atypical depression? Differential response to light therapy.
Psychiatry research 1990;33(2):121-8.
1990: Edward V Nunes; Patrick J McGrath; S Wager; Frederic M Quitkin
Lithium treatment for cocaine abusers with bipolar spectrum disorders.
The American journal of psychiatry 1990;147(5):655-7.
1990: S Wager; D Robinson; R Goetz; E Nunes; R Gully; Frederic M Quitkin
Cholinergic REM sleep induction in atypical depression.
Biological psychiatry 1990;27(4):441-6.
1990: Gerard E Bruder; Jonathan W Stewart; M M Voglmaier; W M Harrison; P McGrath; E Tricamo; Frederic M Quitkin
Cerebral laterality and depression: relations of perceptual asymmetry to outcome of treatment with tricyclic antidepressants.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1990;3(1):1-10.
1990: Jiuan Su Terman; Michael Terman; D Schlager; B Rafferty; M Rosofsky; M J Link; P F Gallin; Frederic M Quitkin
Efficacy of brief, intense light exposure for treatment of winter depression.
Psychopharmacology bulletin 1990;26(1):3-11.
1989: Jonathan W Stewart; Patrick J McGrath; Frederic M Quitkin; W Harrison; J Markowitz; S Wager; M R Leibowitz
Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.
Archives of general psychiatry 1989;46(12):1080-7.
1989: Frederic M Quitkin; Patrick J McGrath; Jonathan W Stewart; W Harrison; S G Wager; E Nunes; Judith G Rabkin; E Tricamo; J Markowitz; donald klein
Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
Archives of general psychiatry 1989;46(9):787-93.
1989: Gerard E Bruder; Frederic M Quitkin; Jonathan W Stewart; C Martin; M M Voglmaier; W M Harrison
Cerebral laterality and depression: differences in perceptual asymmetry among diagnostic subtypes.
Journal of abnormal psychology 1989;98(2):177-86.
1989: Edward V Nunes; Frederic M Quitkin; donald klein
Psychiatric diagnosis in cocaine abuse.
Psychiatry research 1989;28(1):105-14.
1989: Michael Terman; Jiuan Su Terman; Frederic M Quitkin; Patrick J McGrath; Jonathan W Stewart; B Rafferty
Light therapy for seasonal affective disorder. A review of efficacy.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1989;2(1):1-22.
1989: W M Harrison; Patrick J McGrath; Jonathan W Stewart; Frederic M Quitkin
MAOIs and hypertensive crises: the role of OTC drugs.
The Journal of clinical psychiatry 1989;50(2):64-5.
1989: B Parsons; Frederic M Quitkin; Patrick J McGrath; Jonathan W Stewart; E Tricamo; Katja Ocepek-Welikson; W Harrison; Judith G Rabkin; S G Wager; E Nunes
Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression.
Psychopharmacology bulletin 1989;25(4):524-34.
1989: Patrick J McGrath; Jonathan W Stewart; W Harrison; S Wager; E N Nunes; Frederic M Quitkin
A placebo-controlled trial of L-deprenyl in atypical depression.
Psychopharmacology bulletin 1989;25(1):63-7.
1988: Patrick J McGrath; Thomas B Cooper; Frederic M Quitkin; donald klein
Effects of imipramine and phenelzine on plasma PEA levels.
Psychiatry research 1988;26(2):239.
1988: E Nunes; Frederic M Quitkin; C Berman
Panic disorder and depression in female alcoholics.
The Journal of clinical psychiatry 1988;49(11):441-3.
1988: Jonathan W Stewart; Frederic M Quitkin; Patrick J McGrath; Judith G Rabkin; J S Markowitz; E Tricamo; donald klein
Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment.
Psychiatry research 1988;25(2):213-22.
1988: Patrick J McGrath; Jonathan W Stewart; Michael R Liebowitz; J M Markowitz; Frederic M Quitkin; donald klein; J M Gorman
Lactate provocation of panic attacks in depressed outpatients.
Psychiatry research 1988;25(1):41-7.
1988: Vito Agosti; Jonathan W Stewart; Frederic M Quitkin; Judith G Rabkin; Patrick J McGrath; J Markowitz
Factors associated with premature medication discontinuation among responders to an MAOI or a tricyclic antidepressant.
The Journal of clinical psychiatry 1988;49(5):196-8.
1988: Frederic M Quitkin; Jonathan W Stewart; Patrick J McGrath; Michael R Liebowitz; W M Harrison; E Tricamo; donald klein; Judith G Rabkin; J S Markowitz; S G Wager
Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
The American journal of psychiatry 1988;145(3):306-11.
1988: Michael R Liebowitz; Frederic M Quitkin; Jonathan W Stewart; Patrick J McGrath; W M Harrison; J S Markowitz; Judith G Rabkin; E Tricamo; D Goetz; donald klein
Antidepressant specificity in atypical depression.
Archives of general psychiatry 1988;45(2):129-37.
1988: Michael Terman; Jiuan Su Terman; Frederic M Quitkin; T B Cooper; E S Lo; J M Gorman; Jonathan W Stewart; Patrick J McGrath
Response of the melatonin cycle to phototherapy for Seasonal Affective Disorder. Short note.
Journal of neural transmission 1988;72(2):147-65.
1988: M Baron; A Barkai; S Kowalik; R R Fieve; Frederic M Quitkin; R Gruen
Diurnal and circannual variation in platelet 3H-imipramine binding: comparative data on normal and affectively ill subjects.
Neuropsychobiology 1988;19(1):9-11.
1987: Patrick J McGrath; D K Blood; Jonathan W Stewart; W Harrison; Frederic M Quitkin; E Tricamo; J Markowitz
A comparative study of the electrocardiographic effects of phenelzine, tricyclic antidepressants, mianserin, and placebo.
Journal of clinical psychopharmacology 1987;7(5):335-9.
1987: E Nunes; Frederic M Quitkin
Disulfiram and bipolar affective disorder.
Journal of clinical psychopharmacology 1987;7(4):284.
1987: M Baron; A Barkai; R Gruen; E Peselow; R R Fieve; Frederic M Quitkin
Platelet 3H-imipramine binding and familial transmission of affective disorders.
Neuropsychobiology 1987;17(4):182-6.
1987: Michael Terman; Frederic M Quitkin; Jiuan Su Terman; Jonathan W Stewart; Patrick J McGrath
The timing of phototherapy: effects on clinical response and the melatonin cycle.
Psychopharmacology bulletin 1987;23(3):354-7.
1987: J S Markowitz; Judith G Rabkin; J Stewart; E Tricamo; Patrick J McGrath; W Harrison; Katja Ocepek-Welikson; Frederic M Quitkin
Validity assessment of SAFTEE: a preliminary report.
Psychopharmacology bulletin 1987;23(1):102-5.
1986: J G Rabkin; P McGrath; Jonathan W Stewart; W Harrison; J S Markowitz; Frederic M Quitkin
Follow-up of patients who improved during placebo washout.
Journal of clinical psychopharmacology 1986;6(5):274-8.
1986: W Harrison; J Rabkin; J W Stewart; P J McGrath; E Tricamo; Frederic M Quitkin
Phenelzine for chronic depression: a study of continuation treatment.
The Journal of clinical psychiatry 1986;47(7):346-9.
1986: M Baron; A Barkai; R Gruen; E Peselow; R R Fieve; Frederic M Quitkin
Platelet [3H]imipramine binding in affective disorders: trait versus state characteristics.
The American journal of psychiatry 1986;143(6):711-7.
1986: W M Harrison; Judith G Rabkin; Anke A Ehrhardt; Jonathan W Stewart; Patrick J McGrath; D Ross; Frederic M Quitkin
Effects of antidepressant medication on sexual function: a controlled study.
Journal of clinical psychopharmacology 1986;6(3):144-9.
1985: J G Rabkin; Frederic M Quitkin; P McGrath; W Harrison; E Tricamo
Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.
Journal of clinical psychopharmacology 1985;5(1):2-9.
1985: Michael R Liebowitz; Frederic M Quitkin; J W Stewart; P J McGrath; W Harrison; J Rabkin; E Tricamo; J S Markowitz; D F Klein
Effect of panic attacks on the treatment of atypical depressives.
Psychopharmacology bulletin 1985;21(3):558-61.
1985: W M Harrison; J Stewart; Anke A Ehrhardt; J Rabkin; P McGrath; Michael R Liebowitz; Frederic M Quitkin
A controlled study of the effects of antidepressants on sexual function.
Psychopharmacology bulletin 1985;21(1):85-8.
1984: J Rabkin; Frederic M Quitkin; W Harrison; E Tricamo; P McGrath
Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.
Journal of clinical psychopharmacology 1984;4(5):270-8.
1984: W M Harrison; T B Cooper; Jonathan W Stewart; Frederic M Quitkin; Patrick J McGrath; Michael R Liebowitz; J R Rabkin; J S Markowitz; donald klein
The tyramine challenge test as a marker for melancholia.
Archives of general psychiatry 1984;41(7):681-5.
1984: Frederic M Quitkin; W Harrison; Michael R Liebowitz; P McGrath; J G Rabkin; J Stewart; J Markowitz
Defining the boundaries of atypical depression.
The Journal of clinical psychiatry 1984;45(7 Pt 2):19-21.
1984: Michael R Liebowitz; Frederic M Quitkin; J W Stewart; P J McGrath; W Harrison; J Rabkin; E Tricamo; J S Markowitz; donald klein
Phenelzine v imipramine in atypical depression. A preliminary report.
Archives of general psychiatry 1984;41(7):669-77.
1983: M Baron; A Barkai; R Gruen; S Kowalik; Frederic M Quitkin
3H-imipramine platelet binding sites in unipolar depression.
Biological psychiatry 1983;18(12):1403-9.